Trials / Completed
CompletedNCT02792647
A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects
A Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose Escalation Study to Investigate the Safety, Toleration, and Pharmacokinetics of Multiple Oral Doses of IX-01 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Ixchelsis Limited · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the safety and tolerability of IX-01 after multiple doses, and to determine the PK of IX-01 and activity of CYP3A4.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Administered orally |
| DRUG | IX-01 | Administered orally |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-10-01
- First posted
- 2016-06-07
- Last updated
- 2016-11-10
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02792647. Inclusion in this directory is not an endorsement.